Sao Paulo, Brazil

Edson Guimaraes Loturco


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Edson Guimaraes Loturco: Innovator in HIV Assessment

Introduction

Edson Guimaraes Loturco is a notable inventor based in Sao Paulo, Brazil. He has made significant contributions to the field of medical diagnostics, particularly in the assessment of HIV. With a total of 2 patents, his work focuses on improving the accuracy and reliability of HIV screening and diagnosis.

Latest Patents

Loturco's latest patents revolve around metabolic biomarker sets for assessing HIV. These inventions relate to the use of biomarker sets for screening and diagnosing HIV infection. They also predict the immunologic response of a mammalian subject to antiretroviral therapy and provide prognosis for HIV disease progression. Furthermore, his patents include methods for monitoring HIV disease activity in a mammalian subject, along with a kit designed to facilitate these methods. By utilizing the specific biomarkers and methodologies outlined in his patents, healthcare professionals can more accurately assess HIV in patients and predict their therapeutic responses to treatment.

Career Highlights

Throughout his career, Edson Guimaraes Loturco has worked with various companies, including Biocrates Life Sciences AG and IDCGS Clinica de Diagnosticos Medicos. His experience in these organizations has contributed to his expertise in the field of medical diagnostics.

Collaborations

Loturco has collaborated with professionals such as Ismael Dale Cotrim Guerreiro Da Silva and Ricardo Soubie Diaz. These partnerships have likely enhanced his research and development efforts in the area of HIV assessment.

Conclusion

Edson Guimaraes Loturco is a prominent inventor whose work in HIV diagnostics has the potential to significantly impact patient care. His innovative approaches to screening and monitoring HIV disease activity demonstrate his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…